Prothena Corp PLC (PRTA)
followers
·
Follow
| Sector: | CONSUMER STAPLES |
| Industry: | RETAIL - FOOD & DRUG |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Gene G. Kinney |
| Employees: | 130 |
| Web site: | prothena.com |
|
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, L2, D02 VK60
011-353-1-236-2500
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Prothena Corporation plc focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, is in clinical trials for Parkinson's disease; PRX004, which completed Phase I clinical trial.
Please log in first to see chart